Teemu T. Junttila

Ligand-Independent HER2/HER3/PI3K Complex Is Disrupted by Trastuzumab and Is Effectively Inhibited by the PI3K Inhibitor GDC-0941

Teemu T. Junttila, Robert W. Akita, Kathryn L. Parsons et al. · Cancer Cell · 2009 · 831 citations · Full text

Life Sciences, Molecular Biology, Oncology +14

Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIα gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab

Minna Tanner, Maija Hollmén, Teemu T. Junttila et al. · Annals of Oncology · 2005 · 664 citations

Medicine, Cancer Biology, Oncology +15

Trastuzumab-DM1 (T-DM1) retains all the mechanisms of action of trastuzumab and efficiently inhibits growth of lapatinib insensitive breast cancer

Teemu T. Junttila, Guangmin Li, Kathryn L. Parsons et al. · Breast Cancer Research and Treatment · 2010 · 533 citations

Medicine, Oncology, Pharmacology +11

Membrane-Proximal Epitope Facilitates Efficient T Cell Synapse Formation by Anti-FcRH5/CD3 and Is a Requirement for Myeloma Cell Killing

Ji Li, Nicola J. Stagg, Jennifer Johnston et al. · Cancer Cell · 2017 · 292 citations · Full text

Life Sciences, Immunology, Oncology +17

Anti-CD20/CD3 T cell–dependent bispecific antibody for the treatment of B cell malignancies

Liping Sun, Diego Ellerman, Mary Mathieu et al. · Science Translational Medicine · 2015 · 278 citations

Life Sciences, Hematology, Immunology +11